Following the resounding success of the 12th annual WuXi Global Forum during JPM2024, we’re bringing the experience online for colleagues around the world unable to attend in person. Join us for the Digital WuXi Global Forum 2024 on Jan 31, to be premiered at 7-11:30 AM and 7-11:30 PM PST respectively.
This year’s theme, B.O.L.D., focuses on Breaking Barriers, Opening New Horizons, Leading Next Generation, and Delivering for Patients. We will delve deep into what matters most to patients.
Check out the AGENDA below and reserve your complimentary ticket.
Thank you to our distinguished speakers, supportive partners, and thousands of attendees who made our in-person Forum a success. Look forward to connecting with you digitally!
AGENDA:
7:00AM-11:30AM PST and 7:00PM-11:30PM PST, Jan 31 2024
7:00 -7:05 Welcome and Opening Remarks
Hui Cai, Program Chair and Vice President, WuXi AppTec
Minzhang Chen, Co-CEO, WuXi AppTec
7:05 – 7:50 State of Innovation 2024
Amy Abernethy, CMO & President, Product Development, Verily
Donald Ingber, Founding Director & Chaired Professor, Wyss Institute at Harvard University
Mathai Mammen, CEO & Chairman, FogPharma
John Maraganore, CEO, JMM Innovations
Søren Møller, Managing Partner, Seed Investments, Novo Holdings
Session Leader: Christoph Westphal, Co-Founder & General Partner, Longwood Fund
Spotlight on B.O.L.D.
7:50 – 8:25 Breaking Barriers. Leaping Forward.
Robert Gabbay, CSO & CMO, American Diabetes Association
Karen Knudsen, CEO, American Cancer Society and ACS CAN; Professor, Sidney Kimmel Cancer Center at Jefferson Health
Joseph Wu, President, American Heart Association; Director, Stanford Cardiovascular Institute; Co-Founder, Greenstone Biosciences
Session Leader: Margo Georgiadis, Co-Founder & CEO, Montai Health; CEO-Partner, Flagship Pioneering
8:25 – 9:10 Opening Up New Horizons: Spotlight on Cancer
Philip Kantoff, Co-Founder & CEO, Convergent Therapeutics
Samir Khleif, Founder & CEO, Georgiamune
Crystal Mackall, Professor of Pediatrics and Medicine, Stanford University; Director, Stanford Center for Cancer Cell Therapy
Briggs Morrison, CEO, Crossbow Therapeutics
Session Leader: Karen Tkach Tuzman, Director, Biopharma Intelligence, BioCentury
9:10 – 09:55 Leading Transformation: The Next Wave Therapeutics
Wolfram Carius, EVP Pharmaceuticals, Bayer
Abraham Ceesay, CEO, Rapport Therapeutics
Pavan Cheruvu, President & CEO, Bitterroot Bio
Giuseppe “Pino” Ciaramella, Co-Founder & CEO, Orbital Therapeutics; President, Beam Therapeutics
Kevin Forrest, Co-Founder, President & CEO, Kate Therapeutics
Amber Salzman, CEO, Epic Bio
Session Leader: Edward Hu, Vice Chairman, WuXi AppTec; CEO, WuXi Advanced Therapies
09:55 – 10:40 Delivering on Future Platform Solutions
Miles Congreve, CSO, Isomorphic Labs
Evan Feinberg, Co-Founder & CEO, Genesis Therapeutics
Nevan Krogan, Co-Founder & President, Rezo Therapeutics; Professor, Cellular and Molecular Pharmacology, UCSF; Investigator, J. David Gladstone Institutes
Ann Lee-Karlon, President & CEO, EpiBiologics
Sabrina Yang, Co-Founder & CIO, Empress Therapeutics; Principal, Flagship Pioneering
Session Leader: John Carroll, Editor & Founder, Endpoints News
10:40 – 11:30 Scaling Breakthroughs Forward
Vineeta Agarwala, General Partner, Andreessen Horowitz (a16z) Bio + Health
Alexis Borisy, Co-Founder & Chairman, Curie.Bio
Laura Furmanski, Partner, Patient Square Capital
Rogier Rooswinkel, General Partner, Forbion
Tim Shannon, General Partner, Canaan
John Wesley, Investment Director, NVentures
Session Leader: Steve Yang, Co-CEO, WuXi AppTec
